Research On The Identification And Control Of Enterprise Financial Risk

With the rapid development of our country’s economy, the pharmaceutical industry confronts with the fierce market competition and the more strict control for it from government, as well as the management of drug pricing by the government gradually turned to by the market. It makes the pharmaceutical enterprises in our country confront with more pressure than ever before.With growing up of the pharmaceutical industry in our country, the competition between the pharmaceutical enterprises has intensified. The market need them has higher request about capability of innovation and financial management system. They need to adjust themselves in the market competition so as to reduce the potential financial risk. Therefore, the identification and control of financial risk is vital important for an enterprise to maintain normal operation and sustainable development.The domestic and abroad research about the financial risk mainly focuses on the construction of financial risk early warning system for industry, but lack of combining the analysis about whole enterprise’s financial situation with the research about specific financial risk.This paper takes TJ Company as the research object to evaluate its profit ability, operation ability, solvency ability and growth ability by using the financial risk assessment model which was built with efficacy coefficient method based on the characteristics of the pharmaceutical industry’s financial risk. It found TJ Company has financing risk, investment risk and operational risk after analyzing it financial indicators and put forward the control solution according to the TJ Company’s actual situation to ensure its financial situation stable.This paper aims to enhance the enterprise’s financial risk resistance ability and get sustainable development by strengthening enterprise financial risk awareness and building a financial risk early warning system for different condition to take corresponding financial risk assessment and control method. I hope the research conclusion of this paper as a certain reference value for the implementation of the financial risk identification and control of the pharmaceutical enterprises in our country.